Assembly Biosciences
ASMB | NASDAQ
$21.29
+$0.17 (+0.80%)
At close: Nov 16, 2026, 4:00 PM ET
$21.29
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+0.80%
(1D)No price chart data available for 1D timeframe.
Rating
46
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #365/1021 (Top 36%)
Key Statistics
Market Data
Market Cap $463.71M
1D Range
21.00 21.78
52W Range
19.51 38.50
Valuation (TTM)
PE -
PB 1.55
EV/EBITDA -13.79
Valuation (NTM)
Forward PE 12.31
Forward PEG -0.31
Price Target $52.00
Cash Flow
FCF Yield -8.8%
SBC Adj. FCF Yield -10.6%
SBC Impact -20.4%
Margins
Gross Margin 99.9%
Operating Margin -31.8%
FCF Margin -60.7%
Growth (CAGR)
Revenue 3Y | 5Y 43.8% |
55.8%
Dil EPS 3Y | 5Y 101.7% |
60.8%
FCF 3Y | 5Y -129.4% |
22.4%
Returns
ROA -3.4%
ROE -4.4%
ROIC -7.1%
Financial Health
Net Cash
$314.26M
Current Ratio 12.89
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections wit...
Sector Healthcare
Industry Biotechnology
Employees 73
IPO Date Dec 17, 2010
Website www.assemblybio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.93
Miss -41.98%
YoY:
-29.17% REV
$2.96M
Miss -67.42%
YoY:
-72.60%Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$52.00
Upside
+144.25%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ASMB